Evolent appoints Cityblock CEO Toyin Ajayi to board of directors

Evolent Health, Inc.

Dr. Toyin Ajayi appointed to Evolent board effective July 26, 2023, term expires at 2024 annual meeting.
Ajayi is co-founder and CEO of Cityblock, a healthcare company serving Medicaid and dual-eligible populations.
She brings clinical expertise as a physician and experience in value-based care for complex needs patients.
Board determined she is independent under NYSE and SEC rules; standard indemnification agreement entered.
She becomes the ninth independent board member; joins at a time of company evolution, according to CEO.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Toyin Ajayi

Director

EVH · Evolent Health, Inc.

Effective: 2023-07-26
Filed: July 26, 2023, 7:59 PM ET

On July 26, 2023, the Board of Directors (the “Board”) of Evolent Health, Inc, (the “Company”) appointed Dr. Toyin Ajayi to the Board with a term expiring at the Company’s 2024 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Dr. Toyin Ajayi was appointed as Director at Evolent Health, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 26, 2023, the Board of Directors (the “Board”) of Evolent Health, Inc, (the “Company”) appointed Dr. Toyin Ajayi to the Board with a term expiring at the Company’s 2024 annual meeting of stockholders.

View on SEC.gov

Evolent Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628908-23-000115

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.